These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4860334)

  • 21. Structure-activity relationships in the adrenergic-blocking agents.
    Ghouri MS; Haley TJ
    J Pharm Sci; 1969 May; 58(5):511-38. PubMed ID: 4389589
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacology of some phenoxypropanolamine derivatives with beta-adrenolytic effects].
    Engelhardt A; Traunecker W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):203-4. PubMed ID: 5804235
    [No Abstract]   [Full Text] [Related]  

  • 23. Myocardial and local anesthetic actions of beta-adrenergic receptor blocking drugs: relationship to physicochemical properties.
    Levy JV
    Eur J Pharmacol; 1968 Feb; 2(4):250-7. PubMed ID: 4384450
    [No Abstract]   [Full Text] [Related]  

  • 24. Beta-adrenergic blocking agents. 9. Absolute configuration of propranolol and of a number of related aryloxypropanolamines and arylethanolamines.
    Dukes M; Smith LH
    J Med Chem; 1971 Apr; 14(4):326-8. PubMed ID: 4396535
    [No Abstract]   [Full Text] [Related]  

  • 25. [Contribution to the pharmacology of the beta-adrenolytics].
    Wagner J
    Dtsch Med Wochenschr; 1970 Nov; 95(48):2442-8. PubMed ID: 4394708
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cuent pharmacological theory of anti-arrhythmia agents, with special reference to beta-receptor blockaders].
    Takenaka F; Takeya N
    Nihon Rinsho; 1969 Oct; 27(10):2470-8. PubMed ID: 4390982
    [No Abstract]   [Full Text] [Related]  

  • 27. Amidines as adrenergic neurone blocking agents.
    BOURA AL; COPP FC; GREEN AF
    Nature; 1962 Sep; 195():1213-4. PubMed ID: 13871862
    [No Abstract]   [Full Text] [Related]  

  • 28. [Modifications of a rheographic quotient after pharmacological stimulations. II. Action of adrenergic blocking agents].
    TIRELLI G; CAPONNETTO S; SORRENTI R
    Arch Maragliano Patol Clin; 1961 Jun; 17():413-8. PubMed ID: 13777011
    [No Abstract]   [Full Text] [Related]  

  • 29. CONFORMATION OF N-(BETA-CHLOROETHYL)-2-PHENOXYETHYLAMINES IN RELATION TO ADRENERGIC BLOCKING ACTIVITY.
    BELLEAU B; COOPER P
    J Med Chem; 1963 Sep; 6():579-83. PubMed ID: 14173588
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism of drug action at receptor surfaces--III. Chemical reactivity and conformation of spiroethylenimmonium ions in relation to adrenergic blocking activity.
    BELLEAU B
    J Med Pharm Chem; 1959 Aug; 1():343-54. PubMed ID: 13798538
    [No Abstract]   [Full Text] [Related]  

  • 31. An analysis of adrenergic blocking activity.
    LEVY B; AHLQUIST RP
    J Pharmacol Exp Ther; 1961 Aug; 133():202-10. PubMed ID: 13761587
    [No Abstract]   [Full Text] [Related]  

  • 32. Failure of adrenergic and cholinergic blocking agents to block ovulation in the rat.
    MOORE WW
    Am J Physiol; 1961 Jun; 200():1293-5. PubMed ID: 13772373
    [No Abstract]   [Full Text] [Related]  

  • 33. [New adrenergic neuroblocking guanadine derivatives].
    Toldy L; Reiter J; Szilágyi G; Gimesi I; Borsy J
    Acta Pharm Hung; 1968 Jun; 38(2):63-7. PubMed ID: 5723279
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of adrenergic blocking agents on some metabolic actions of catecholamines.
    MAYER S; MORAN NC; FAIN J
    J Pharmacol Exp Ther; 1961 Oct; 134():18-27. PubMed ID: 14471716
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of adrenergic blocking agents and of chlorpromazine on blood pressure increase by vasopressin and angiotensin.
    SUPEK Z; UROIC B; GJURIS V; MARIJAN N
    J Pharm Pharmacol; 1962 May; 14():284-7. PubMed ID: 13918447
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of sodium thiosulfate on the adrenergic blocking action of 2-carboxybenzeneseleninic acid.
    LIMONGI JP; GIESBRECHT AM
    Arch Int Pharmacodyn Ther; 1960 Oct; 128():1-5. PubMed ID: 13762198
    [No Abstract]   [Full Text] [Related]  

  • 37. Second symposium on catecholamines. Adrenergic transmission. Introductory remarks.
    Burn JH
    Pharmacol Rev; 1966 Mar; 18(1):459-70. PubMed ID: 5904161
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of ring substitution in 1-isopropylamino-3-phenoxypropan-2-ol on beta-adrenoceptor inhibition.
    Barrett AM; Wale JL
    Eur J Pharmacol; 1970; 12(3):372-4. PubMed ID: 4395558
    [No Abstract]   [Full Text] [Related]  

  • 39. Adrenergic neurone blocking tropine derivatives with long-lasting hypotensive action.
    DODA M; GYORGY L; NADOR K
    Nature; 1962 Sep; 195():1108-9. PubMed ID: 13886833
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of adrenergic blocking agents on running ability in the rat.
    SRETER FA; FRIEDMAN SM
    Am J Physiol; 1959 Aug; 197():478-82. PubMed ID: 13833536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.